Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (111-120 of 407) with videos related to

Pageof 41
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1982
Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopaA Reches, D Jiang, S Fahn
Neurology|November 1, 1994
Oral and genital tardive pain syndromesB Ford, P Greene, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Intrathecal baclofen in the treatment of dystonic stormA Dalvi, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 1999
French horn embouchure dystoniaS Frucht, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's diseaseE Fazzini, J Fleming, S Fahn
Progress in Brain Research|January 1, 1990
Antimuscarinic drugs in the treatment of movement disordersS Fahn, R Burke, Y Stern
Neurologia (Barcelona, Spain)|September 1, 1987
[New therapeutic alternatives in Parkinson disease]J García de Yébenes, S Fahn
Current Opinion in Neurology|September 2, 1998
Fetal tissue transplantation [correction of transplanation] in Parkinson's diseaseS Tabbal, S Fahn, S Frucht
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugsP Greene, H Shale, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
The characterization and outcome of stereotypical movements in nonautistic childrenA Tan, M Salgado, S Fahn
Pageof 41

Showing results (111-120 of 407) with videos related to

Sort By:
Pageof 41
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1982
Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopaA Reches, D Jiang, S Fahn
Neurology|November 1, 1994
Oral and genital tardive pain syndromesB Ford, P Greene, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Intrathecal baclofen in the treatment of dystonic stormA Dalvi, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 1999
French horn embouchure dystoniaS Frucht, S Fahn, B Ford
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's diseaseE Fazzini, J Fleming, S Fahn
Progress in Brain Research|January 1, 1990
Antimuscarinic drugs in the treatment of movement disordersS Fahn, R Burke, Y Stern
Neurologia (Barcelona, Spain)|September 1, 1987
[New therapeutic alternatives in Parkinson disease]J García de Yébenes, S Fahn
Current Opinion in Neurology|September 2, 1998
Fetal tissue transplantation [correction of transplanation] in Parkinson's diseaseS Tabbal, S Fahn, S Frucht
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugsP Greene, H Shale, S Fahn
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
The characterization and outcome of stereotypical movements in nonautistic childrenA Tan, M Salgado, S Fahn
Pageof 41